15 Important AI News and Ratings on Investors’ Radar

Page 5 of 15

11. Tempus AI, Inc (NASDAQ:TEM)

Number of Hedge Fund Holders: 7

Tempus AI, Inc (NASDAQ:TEM) is a healthcare technology company that provides AI-enabled precision medicine solutions. On January 13, the technology company announced the development of its first whole-genome sequencing test, xH, using artificial intelligence. This test aims to enhance precision medicine and patient care, particularly in hematological ontology. Tempus will be building on its AI-enabled diagnostic platform with xH, helping facilitate personalized treatment decisions as well as a more precise understanding of patients’ unique genetic profiles. xH is currently available for research use only (RUO) and will be clinically available within the next year.

“xH is our first product leveraging the full genome in our effort to provide meaningful insights into complex diseases. By scaling whole-genome sequencing, we are positioned to transform patient care in hematological oncology and eventually all solid tumors, shaping the future of precision medicine and accelerating therapeutic advancements in partnership with the pharmaceutical community”.

-Eric Lefkofsky, Founder and CEO of Tempus.

Page 5 of 15